Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

The University of British Columbia

$38,000.00

Developing novel cell penetrating peptides (CPPs) for protein delivery into the nucleus of cells

FY 2023-24

Summary
Intracellular delivery of proteins remains challenging. The current state-of-the-art cell penetrating peptides (CPPs), such as R8, facilitate protein transport across the cell membrane, but majority of the proteins are trapped in the lysosomes and degraded. We discovered that proteins can be targeted to the nucleus of cells by simply incubating the cells with the protein in the presence of peptides extracted from salmon sperm (aka. protamine). My research program will focus on 3 objectives to develop novel CPPs from protamine for enhanced protein delivery to the nucleus of cells and use them to deliver gene editing components to cells and animals, with a long-term vision of generating models to study fundamental biological questions. Obj 1: Identify the most potent CPP sequence (pCPP) in protamine and synthesize further enhanced CPPs. There are 4 different peptides in protamine, and we will identify the most potent one (pCPP). We hypothesize that the nuclear delivery activity of pCPP can be enhanced by crosslinking pCPPs or conjugating a lipid to pCPP. These modifications will increase pCPP interaction with cell membrane, facilitating intracellular and nuclear delivery of proteins. Obj 2: Delivery of CRISPR/Cas9 gene editing components in 2D/3D cell culture using the novel CPPs. One utility of these novel CPPs is to deliver gene editing components to the nucleus of cells to edit a target gene. We will demonstrate this by using an engineered cell line that was transduced with a green fluorescence protein (GFP) gene containing a point mutation, which will be corrected by CRISPR/Cas9 through the guide RNA (gRNA) and a donor DNA delivered to the nucleus by our novel CPPs. The gene editing efficiency will be measured and we will optimize the treatment conditions to achieve optimal effects. Obj 3: Delivery of CRISPR/Cas9 based gene editing components to tissues in mice using the novel CPPs. Using a transgenic mouse line that contains a point mutated GFP gene in their genome, successful delivery of CRISPR/Cas9 components by CPPs will cause the corrected cells to fluoresce. We will adopt the optimal formulation identified from Obj2 and locally deliver it to various tissues in mice, including muscle, lungs, brain, and eyes, and monitor GFP expression to provide information: (1) dose-dependence of gene editing effect; (2) optimal dosage; (3) editing duration; (4) editing selectivity/efficacy. To our knowledge, we are the first group to show that protamine can target proteins to the nucleus by simple physical mixing without chemical conjugation. This improves the convenience of using this as a platform for protein delivery. We will develop novel CPPs from protamine with enhanced nuclear delivery. This research direction has not been pursued by others to a significant extent. This program will offer training for 12 HQP (4 PhD, 2 MSc, 6 undergrad), including peptide synthesis, formulation development, cell-based and genomic assays, and animal studies.
Program
Discovery Grants Program - Individual
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2023-04020
Name nom
Li, Shyh-Dar
Department département
Faculty of Pharmaceutical Sciences
Organization id
2
Institution établissement
The University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
38000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Chemical engineering
Research subject en
Génie chimique
Research subject fr
Génie chimique
Application title
Developing novel cell penetrating peptides (CPPs) for protein delivery into the nucleus of cells
Keyword
Cell penetrating peptide; Chemical engineering; Drug delivery; Drug delivery to nucleus of cells; Protein delivery; Transmembrane delivery
Application summary
Intracellular delivery of proteins remains challenging. The current state-of-the-art cell penetrating peptides (CPPs), such as R8, facilitate protein transport across the cell membrane, but majority of the proteins are trapped in the lysosomes and degraded. We discovered that proteins can be targeted to the nucleus of cells by simply incubating the cells with the protein in the presence of peptides extracted from salmon sperm (aka. protamine). My research program will focus on 3 objectives to develop novel CPPs from protamine for enhanced protein delivery to the nucleus of cells and use them to deliver gene editing components to cells and animals, with a long-term vision of generating models to study fundamental biological questions. Obj 1: Identify the most potent CPP sequence (pCPP) in protamine and synthesize further enhanced CPPs. There are 4 different peptides in protamine, and we will identify the most potent one (pCPP). We hypothesize that the nuclear delivery activity of pCPP can be enhanced by crosslinking pCPPs or conjugating a lipid to pCPP. These modifications will increase pCPP interaction with cell membrane, facilitating intracellular and nuclear delivery of proteins. Obj 2: Delivery of CRISPR/Cas9 gene editing components in 2D/3D cell culture using the novel CPPs. One utility of these novel CPPs is to deliver gene editing components to the nucleus of cells to edit a target gene. We will demonstrate this by using an engineered cell line that was transduced with a green fluorescence protein (GFP) gene containing a point mutation, which will be corrected by CRISPR/Cas9 through the guide RNA (gRNA) and a donor DNA delivered to the nucleus by our novel CPPs. The gene editing efficiency will be measured and we will optimize the treatment conditions to achieve optimal effects. Obj 3: Delivery of CRISPR/Cas9 based gene editing components to tissues in mice using the novel CPPs. Using a transgenic mouse line that contains a point mutated GFP gene in their genome, successful delivery of CRISPR/Cas9 components by CPPs will cause the corrected cells to fluoresce. We will adopt the optimal formulation identified from Obj2 and locally deliver it to various tissues in mice, including muscle, lungs, brain, and eyes, and monitor GFP expression to provide information: (1) dose-dependence of gene editing effect; (2) optimal dosage; (3) editing duration; (4) editing selectivity/efficacy. To our knowledge, we are the first group to show that protamine can target proteins to the nucleus by simple physical mixing without chemical conjugation. This improves the convenience of using this as a platform for protein delivery. We will develop novel CPPs from protamine with enhanced nuclear delivery. This research direction has not been pursued by others to a significant extent. This program will offer training for 12 HQP (4 PhD, 2 MSc, 6 undergrad), including peptide synthesis, formulation development, cell-based and genomic assays, and animal studies.